Migracap-Plus Tablet SR
By Migracap-Plus
Rx
20 Tablet SR in a Strip

Composition
Propranolol(40mg) + Flunarizine(10mg)

Manufacturer - Mabril Healthcare Pvt Ltd
C- 36, Kendriya Vihar Jankipuram Ext, Sector-6, Lucknow-22

Expires on or after
July, 2025

liver
Caution is advised when using Migracap-Plus Tablet SR in patients with liver disease. It may be necessary to adjust the dosage of the medication in such cases. It is important to consult with your doctor before taking Migracap-Plus Tablet SR if you have liver issues. Regular monitoring of blood pressure is recommended to ensure the correct dose adjustments are made accordingly.

kidney
Migracap-Plus Tablet SR is likely safe for patients with kidney disease. Limited data shows dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol when taking Migracap-Plus Tablet SR to avoid harmful effects.

driving
Migracap-Plus Tablet SR may lead to side effects like visual disturbances, hallucinations, fatigue, mental confusion, dizziness, or tiredness, impacting driving ability.

pregnancy
Migracap-Plus Tablet SR is considered unsafe during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. It's important to consult your doctor regarding its use during pregnancy.

breastfeeding
It is better to consult your doctor before using Migracap-Plus Tablet SR during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹228
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024